These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6965424)

  • 1. Production of alloreactive T-cell lymphomas.
    Fathman CG; Weissman IL
    Nature; 1980 Jan; 283(5745):404-6. PubMed ID: 6965424
    [No Abstract]   [Full Text] [Related]  

  • 2. Phenotypic heterogeneity of Moloney leukemia virus-induced T cel lymphomas.
    Pepersack L; Lee JC; McEwan R; Ihle JN
    J Immunol; 1980 Jan; 124(1):279-85. PubMed ID: 6965293
    [No Abstract]   [Full Text] [Related]  

  • 3. Interleukin-2 and antibody to the T cell receptor regulate proliferation of a radiation leukemia virus-transformed T cell lymphoma.
    O'Neill HC
    Leukemia; 1988 Feb; 2(2):108-14. PubMed ID: 2830440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transformation of thymocytes by thymus epithelium derived from AKR mice.
    Waksal SD; Smolinsky S; Cohen IR; Feldman M
    Nature; 1976 Oct; 263(5577):512-4. PubMed ID: 1085917
    [No Abstract]   [Full Text] [Related]  

  • 5. A simple method for the quantitation of specific cytotoxic precursors to syngeneic tumors.
    Teh HS; Kwong L; Yu M; Kilburn DG
    J Immunol Methods; 1981; 46(1):97-111. PubMed ID: 7026690
    [No Abstract]   [Full Text] [Related]  

  • 6. Virus-specific T cell response prevents lymphoma development in mice infected by intrathymic inoculation of Moloney leukaemia virus (M-MuLV).
    Zanovello P; Collavo D; Ronchese F; De Rossi A; Biasi G; Chieco-Bianchi L
    Immunology; 1984 Jan; 51(1):9-16. PubMed ID: 6228521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The augmentation of in vitro and in vivo tumor-specific T cell-mediated immunity by amplifier T lymphocytes.
    Fujiwara H; Hamaoka T; Shearer GM; Yamamoto H; Terry WD
    J Immunol; 1980 Feb; 124(2):863-9. PubMed ID: 6965392
    [No Abstract]   [Full Text] [Related]  

  • 8. Characterization of malignant cell populations in MNU-induced leukaemia of mice.
    Baines P; Dexter TM; Schofield R
    Leuk Res; 1979; 3(1):23-8. PubMed ID: 316844
    [No Abstract]   [Full Text] [Related]  

  • 9. Recent studies on the role of the immune response in resistance to virus-induced leukemias and lymphomas.
    Meruelo D; McDevitt HO
    Semin Hematol; 1978 Oct; 15(4):399-419. PubMed ID: 216115
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on the role of the host immune response in recovery from Friend virus leukemia. II. Cell-mediated immunity.
    Chesebro B; Wehrly K
    J Exp Med; 1976 Jan; 143(1):85-99. PubMed ID: 1081583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of lymphocyte surface antigen expression by the use of variant cell lines.
    Hyman R; Trowbridge I
    Cold Spring Harb Symp Quant Biol; 1977; 41 Pt 1():407-15. PubMed ID: 302193
    [No Abstract]   [Full Text] [Related]  

  • 12. Spontaneous antilymphoma reaction of preleukaemic AKR mice is a non-T-cell killing.
    Gomard E; Leclerc JC; Levy JP
    Nature; 1974 Aug; 250(5468):671-3. PubMed ID: 4854374
    [No Abstract]   [Full Text] [Related]  

  • 13. The in vitro generation of H-2-restricted cytotoxic T cells to AKR/Gross leukemia virus-induced tumors. I. Requirement for stimulation with allogeneic leukemia cells in vivo.
    Green WR
    J Immunol; 1982 Mar; 128(3):1043-9. PubMed ID: 6976986
    [No Abstract]   [Full Text] [Related]  

  • 14. Induction, establishment in vitro, and characterization of functional, antigen-specific, carrier-primed murine T-cell lymphomas.
    Finn OJ; Boniver J; Kaplan HS
    Proc Natl Acad Sci U S A; 1979 Aug; 76(8):4033-7. PubMed ID: 91171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible immunological mechanisms in C-type viral leukemogenesis in mice.
    Ihle JN; Lee JC
    Curr Top Microbiol Immunol; 1982; 98():85-101. PubMed ID: 6282538
    [No Abstract]   [Full Text] [Related]  

  • 16. Receptors for immunoglobulin and complement on mouse leukemias and lymphomas.
    Shevach E; Herberman R; Lieberman R; Frank MM; Green I
    J Immunol; 1972 Feb; 108(2):325-8. PubMed ID: 4340285
    [No Abstract]   [Full Text] [Related]  

  • 17. T cell-mediated immunity to oncornavirus-induced tumors. IV. Preliminary evidence for a specific suppression of anti-Moloney cell-mediated immune response by autoimmune T cells.
    Leclerc JC; Plater C; Connan F; Debré P
    Eur J Immunol; 1981 Jan; 11(1):45-7. PubMed ID: 6452279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-cell growth factor (interleukin 2) control of T-lymphocyte proliferation: possible involvement in leukemogenesis.
    Gillis S; Mertelsmann R; Moore MA
    Transplant Proc; 1981 Dec; 13(4):1884-90. PubMed ID: 6977222
    [No Abstract]   [Full Text] [Related]  

  • 19. Pathological and immunological identification of target cells for murine leukemia viruses in rats.
    Takeichi N; Suzuki K; Kasai M; Moriuchi T; Kobayashi H
    Nihon Ketsueki Gakkai Zasshi; 1982 Dec; 45(7):1277-86. PubMed ID: 6301193
    [No Abstract]   [Full Text] [Related]  

  • 20. [Current and prospective problems in tumor immunology].
    Pitzurra M
    Boll Ist Sieroter Milan; 1971; 50(3):209-20. PubMed ID: 4947785
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.